SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 10% Stake in Elanco Animal Health
Beneficial Ownership Report
FMR LLC and its affiliates, along with Abigail P. Johnson, have reported a combined beneficial ownership of 10.0% of Elanco Animal Health Inc.'s common stock as of February 28, 2025.
Summary
- FMR LLC and Abigail P. Johnson jointly filed an amended Schedule 13G for Elanco Animal Health Inc.
- As of February 28, 2025, they beneficially own an aggregate of 49,541,123.27 shares of Elanco Animal Health Inc. common stock.
- This represents 10.0% of the total outstanding common stock of Elanco Animal Health Inc.
- FMR LLC holds sole voting power over 42,794,054.04 shares and sole dispositive power over 49,541,123.27 shares.
- Abigail P. Johnson holds sole dispositive power over 49,541,123.27 shares, with no sole or shared voting power directly.
- The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- Fidelity Management & Research Company LLC, a subsidiary of FMR LLC, is specifically noted as beneficially owning 5% or greater of the outstanding shares.
- Abigail P. Johnson is a Director, Chairman, and Chief Executive Officer of FMR LLC, and is part of the Johnson family who are predominant owners of FMR LLC's voting shares.
Sentiment
Score: 7
Explanation: The document indicates a significant, passive institutional investment in Elanco Animal Health Inc. by FMR LLC and Abigail P. Johnson, which is generally a positive signal of confidence. However, it is a routine disclosure and does not contain new operational or financial news from the company itself.
Positives
- A major institutional investor (FMR LLC) and its principal (Abigail P. Johnson) hold a significant 10% stake, indicating substantial confidence in Elanco Animal Health Inc.'s long-term prospects.
- The filing explicitly states the shares are held in the ordinary course of business and not for control-influencing purposes, suggesting a stable, passive investment rather than an activist stance.
Negatives
- The document is a routine ownership disclosure and does not contain specific operational or financial updates from Elanco Animal Health Inc. itself, limiting insights into the company's recent performance.
Future Outlook
The document is a beneficial ownership report and does not provide forward-looking statements or guidance regarding Elanco Animal Health Inc.'s future performance or FMR LLC's investment strategy beyond the certification that shares are held in the ordinary course of business.
Management Comments
- "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."
Industry Context
This filing indicates a significant passive investment by a major asset manager in the animal health sector. While it doesn't provide specific industry analysis, the substantial stake by FMR LLC suggests continued institutional interest in companies within the animal health industry, which is generally seen as resilient due to consistent demand for pet care and livestock health products.
Comparison to Industry Standards
- This document is a standard Schedule 13G filing, reporting beneficial ownership. It does not contain financial results or operational data from Elanco Animal Health Inc. that would allow for a direct comparison to industry-specific financial benchmarks or competitor performance (e.g., Zoetis, Merck Animal Health, Boehringer Ingelheim Animal Health). The filing's purpose is solely to disclose a significant ownership stake by an institutional investor.
Stakeholder Impact
- Shareholders: Increased transparency regarding significant institutional ownership. The large stake by FMR LLC could be viewed positively as a vote of confidence in Elanco Animal Health Inc.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC where its Power of Attorney was incorporated by reference. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC where Abigail P. Johnson's Power of Attorney was incorporated by reference. |
| 2025-02-28 | Date of event which requires filing of this statement (beneficial ownership snapshot date). |
| 2025-03-06 | Date of joint filing agreement and signature date for the Schedule 13G. |
Keywords
Elanco Animal Health Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Animal Health, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.